In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
Clinical trial results reported at the AACR Annual Meeting 2025 showcased new therapeutic approaches for non-small cell lung cancer....
During the Presidential Select Symposium at the AACR Annual Meeting 2025, Patricia M. LoRusso, DO, PhD(h), FAACR, led a...
For April 2025, the editors of AACR's 10 journals highlighted studies on evolution in glioblastoma, new cancer treatment approaches,...
Takeaways from the final day of the AACR Annual Meeting 2025 included the biggest discoveries presented, a look at...
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...
Takeaways from day 4 of the AACR Annual Meeting 2025 include declining breast cancer mortality, using liquid and tissue...
Takeaways from day four of the AACR Annual Meeting 2025 included data on one-dose HPV vaccination, technology advancing research,...